应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
SYRE SPYRE THERAPEUTICS INC
交易中 12-23 15:26:44 EST
23.24
-0.62
-2.62%
最高
23.85
最低
22.79
成交量
15.15万
今开
23.52
昨收
23.86
日振幅
4.42%
总市值
13.63亿
流通市值
10.63亿
总股本
5,867万
成交额
354.55万
换手率
0.33%
流通股本
4,577万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Spyre Therapeutics, Inc.盘中异动 大幅上涨5.06%报24.30美元
市场透视 · 12-21
Spyre Therapeutics, Inc.盘中异动 大幅上涨5.06%报24.30美元
Spyre Therapeutics, Inc.盘中异动 急速跳水5.03%报23.99美元
市场透视 · 12-19
Spyre Therapeutics, Inc.盘中异动 急速跳水5.03%报23.99美元
Spyre Therapeutics, Inc.盘中异动 早盘大幅下跌5.04%报23.19美元
市场透视 · 12-17
Spyre Therapeutics, Inc.盘中异动 早盘大幅下跌5.04%报23.19美元
Spyre Therapeutics, Inc.盘中异动 下午盘急速下挫5.05%报25.11美元
市场透视 · 12-13
Spyre Therapeutics, Inc.盘中异动 下午盘急速下挫5.05%报25.11美元
Spyre Therapeutics, Inc.盘中异动 大幅拉升5.09%报26.85美元
市场透视 · 12-06
Spyre Therapeutics, Inc.盘中异动 大幅拉升5.09%报26.85美元
Spyre Therapeutics, Inc.盘中异动 早盘股价大涨5.03%报29.04美元
市场透视 · 12-03
Spyre Therapeutics, Inc.盘中异动 早盘股价大涨5.03%报29.04美元
Spyre Therapeutics, Inc.盘中异动 股价大涨5.78%
市场透视 · 11-21
Spyre Therapeutics, Inc.盘中异动 股价大涨5.78%
Spyre Therapeutics, Inc.盘中异动 早盘快速下跌5.21%报27.18美元
市场透视 · 11-19
Spyre Therapeutics, Inc.盘中异动 早盘快速下跌5.21%报27.18美元
Spyre Therapeutics, Inc.2024财年第三财季实现净利润-69.03百万美元,同比减少72.10%
市场透视 · 11-16
Spyre Therapeutics, Inc.2024财年第三财季实现净利润-69.03百万美元,同比减少72.10%
Spyre Therapeutics, Inc.盘中异动 大幅下跌5.06%
市场透视 · 11-01
Spyre Therapeutics, Inc.盘中异动 大幅下跌5.06%
Spyre Therapeutics, Inc.盘中异动 临近收盘急速上涨5.06%报34.07美元
市场透视 · 10-23
Spyre Therapeutics, Inc.盘中异动 临近收盘急速上涨5.06%报34.07美元
美国研究综述-Cadence Design Systems、Equity Bancshares、标普全球
Reuters · 10-15
美国研究综述-Cadence Design Systems、Equity Bancshares、标普全球
Spyre Therapeutics, Inc.盘中异动 股价大涨5.09%报29.94美元
市场透视 · 10-01
Spyre Therapeutics, Inc.盘中异动 股价大涨5.09%报29.94美元
Spyre Therapeutics, Inc.盘中异动 股价大跌5.22%
市场透视 · 09-24
Spyre Therapeutics, Inc.盘中异动 股价大跌5.22%
Spyre Therapeutics, Inc.盘中异动 下午盘股价大涨5.04%报30.42美元
市场透视 · 09-20
Spyre Therapeutics, Inc.盘中异动 下午盘股价大涨5.04%报30.42美元
Spyre Therapeutics Inc 预计每股亏损 95 美分 - 财报前瞻
Reuters · 08-07
Spyre Therapeutics Inc 预计每股亏损 95 美分 - 财报前瞻
加载更多
公司概况
公司名称:
SPYRE THERAPEUTICS INC
所属市场:
NASDAQ
上市日期:
--
主营业务:
Spyre Therapeutics, Inc.于2013年12月16日从特拉华州有限责任公司转换而来。该公司是一家生物技术公司,旨在通过结合同类最佳的抗体工程、合理的治疗组合以及用于患者选择的精准医疗方法,创造下一代炎症性肠病(IBD)产品。Spyre的产品线包括针对α4β7、TL1A和IL-23的延长半衰期抗体。
发行价格:
--
{"stockData":{"symbol":"SYRE","market":"US","secType":"STK","nameCN":"SPYRE THERAPEUTICS INC","latestPrice":23.235,"timestamp":1734985583163,"preClose":23.86,"halted":0,"volume":151474,"delay":0,"floatShares":45770398,"shares":58670608,"eps":-5.788806,"marketStatus":"交易中","marketStatusCode":2,"change":-0.625,"latestTime":"12-23 15:26:44 EST","open":23.52,"high":23.845,"low":22.79,"amount":3545510.8685459998,"amplitude":0.044216,"askPrice":23.26,"askSize":217,"bidPrice":23.21,"bidSize":194,"shortable":3,"etf":0,"ttmEps":-5.788806,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1734987600000},"adr":0,"listingDate":1460001600000,"adjPreClose":23.86,"preHourTrading":{"tag":"盘前","latestPrice":22.01,"preClose":23.86,"latestTime":"04:01 EST","volume":2,"amount":42.02,"timestamp":1734944461451},"postHourTrading":{"tag":"盘后","latestPrice":23.86,"preClose":23.86,"latestTime":"16:20 EST","volume":59298,"amount":1414849.808,"timestamp":1734729600642},"volumeRatio":0.236129,"impliedVol":0.7549,"impliedVolPercentile":0.4722},"requestUrl":"/m/hq/s/SYRE","defaultTab":"news","newsList":[{"id":"2493425770","title":"Spyre Therapeutics, Inc.盘中异动 大幅上涨5.06%报24.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493425770","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493425770?lang=zh_cn&edition=full","pubTime":"2024-12-21 00:30","pubTimestamp":1734712242,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日00时30分,Spyre Therapeutics, Inc.股票出现波动,股价大幅上涨5.06%。Spyre Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.27%。Spyre Therapeutics, Inc.公司简介:Spyre Therapeutics Inc 是一家生物技术公司,旨在通过结合抗体工程,合理的治疗组合和精确的医学方法来为患者选择,创造下一代炎症性肠病产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221003042a1fe5b0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221003042a1fe5b0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SYRE","BK4139"],"gpt_icon":0},{"id":"2492155313","title":"Spyre Therapeutics, Inc.盘中异动 急速跳水5.03%报23.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492155313","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492155313?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:07","pubTimestamp":1734552461,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时07分,Spyre Therapeutics, Inc.股票出现波动,股价急速下跌5.03%。Spyre Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.97%。Spyre Therapeutics, Inc.公司简介:Spyre Therapeutics Inc 是一家生物技术公司,旨在通过结合抗体工程,合理的治疗组合和精确的医学方法来为患者选择,创造下一代炎症性肠病产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121904074195ea59dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121904074195ea59dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","SYRE"],"gpt_icon":0},{"id":"2492961697","title":"Spyre Therapeutics, Inc.盘中异动 早盘大幅下跌5.04%报23.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492961697","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492961697?lang=zh_cn&edition=full","pubTime":"2024-12-17 23:28","pubTimestamp":1734449302,"startTime":"0","endTime":"0","summary":"北京时间2024年12月17日23时28分,Spyre Therapeutics, Inc.股票出现异动,股价急速跳水5.04%。Spyre Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.51%。Spyre Therapeutics, Inc.公司简介:Spyre Therapeutics Inc 是一家生物技术公司,旨在通过结合抗体工程,合理的治疗组合和精确的医学方法来为患者选择,创造下一代炎症性肠病产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217232823ab7f6f5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217232823ab7f6f5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SYRE","BK4139","LENZ"],"gpt_icon":0},{"id":"2491435355","title":"Spyre Therapeutics, Inc.盘中异动 下午盘急速下挫5.05%报25.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491435355","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491435355?lang=zh_cn&edition=full","pubTime":"2024-12-13 02:51","pubTimestamp":1734029476,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日02时51分,Spyre Therapeutics, Inc.股票出现波动,股价大幅下挫5.05%。Spyre Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.00%。Spyre Therapeutics, Inc.公司简介:Spyre Therapeutics Inc 是一家生物技术公司,旨在通过结合抗体工程,合理的治疗组合和精确的医学方法来为患者选择,创造下一代炎症性肠病产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121302511695e93fc2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121302511695e93fc2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SYRE","LENZ"],"gpt_icon":0},{"id":"2489232321","title":"Spyre Therapeutics, Inc.盘中异动 大幅拉升5.09%报26.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489232321","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489232321?lang=zh_cn&edition=full","pubTime":"2024-12-06 23:34","pubTimestamp":1733499275,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日23时34分,Spyre Therapeutics, Inc.股票出现波动,股价大幅上涨5.09%。Spyre Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.64%。Spyre Therapeutics, Inc.公司简介:Spyre Therapeutics Inc 是一家生物技术公司,旨在通过结合抗体工程,合理的治疗组合和精确的医学方法来为患者选择,创造下一代炎症性肠病产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206233435ab62f616&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206233435ab62f616&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SYRE","BK4139","LENZ"],"gpt_icon":0},{"id":"2488941896","title":"Spyre Therapeutics, Inc.盘中异动 早盘股价大涨5.03%报29.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488941896","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488941896?lang=zh_cn&edition=full","pubTime":"2024-12-03 23:03","pubTimestamp":1733238204,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日23时03分,Spyre Therapeutics, Inc.股票出现波动,股价急速拉升5.03%。截至发稿,该股报29.04美元/股,成交量14.647万股,换手率0.25%,振幅5.46%。Spyre Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.39%。Spyre Therapeutics, Inc.公司简介:Spyre Therapeutics Inc 是一家生物技术公司,旨在通过结合抗体工程,合理的治疗组合和精确的医学方法来为患者选择,创造下一代炎症性肠病产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203230324abf3098b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203230324abf3098b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SYRE","LENZ","BK4139"],"gpt_icon":0},{"id":"2485497702","title":"Spyre Therapeutics, Inc.盘中异动 股价大涨5.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485497702","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485497702?lang=zh_cn&edition=full","pubTime":"2024-11-21 22:31","pubTimestamp":1732199484,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日22时31分,Spyre Therapeutics, Inc.股票出现异动,股价急速拉升5.78%。Spyre Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.22%。Spyre Therapeutics, Inc.公司简介:Spyre Therapeutics Inc 是一家生物技术公司,旨在通过结合抗体工程,合理的治疗组合和精确的医学方法来为患者选择,创造下一代炎症性肠病产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121223124971a7df2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121223124971a7df2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SYRE","LENZ","BK4139"],"gpt_icon":0},{"id":"2484923322","title":"Spyre Therapeutics, Inc.盘中异动 早盘快速下跌5.21%报27.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484923322","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484923322?lang=zh_cn&edition=full","pubTime":"2024-11-19 22:31","pubTimestamp":1732026688,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日22时31分,Spyre Therapeutics, Inc.股票出现波动,股价快速跳水5.21%。Spyre Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.46%。Spyre Therapeutics, Inc.公司简介:Spyre Therapeutics Inc 是一家生物技术公司,旨在通过结合抗体工程,合理的治疗组合和精确的医学方法来为患者选择,创造下一代炎症性肠病产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119223128a245efa5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119223128a245efa5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SYRE","LENZ","BK4139"],"gpt_icon":0},{"id":"2483930985","title":"Spyre Therapeutics, Inc.2024财年第三财季实现净利润-69.03百万美元,同比减少72.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483930985","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483930985?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:00","pubTimestamp":1731686436,"startTime":"0","endTime":"0","summary":"11月16日,Spyre Therapeutics, Inc.公布财报,公告显示公司2024财年第三财季净利润为-69.03百万美元,同比减少72.10%;其中营业收入为0.00美元,每股基本收益为-1.36美元。从资产负债表来看,Spyre Therapeutics, Inc.总负债93.70百万美元,其中短期债务0.00美元,资产负债比为0.05,流动比率为0.08。机构评级:截至2024年11月16日,当前有8家机构对Spyre Therapeutics, Inc.目标价做出预测,其中目标均价为58.62美元,其中最低目标价为40.00美元,最高目标价为71.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000323a23b89e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000323a23b89e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SYRE","LENZ"],"gpt_icon":0},{"id":"2480005250","title":"Spyre Therapeutics, Inc.盘中异动 大幅下跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480005250","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480005250?lang=zh_cn&edition=full","pubTime":"2024-11-01 01:48","pubTimestamp":1730396898,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日01时48分,Spyre Therapeutics, Inc.股票出现波动,股价快速下跌5.06%。Spyre Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为3.67%。Spyre Therapeutics, Inc.公司简介:Spyre Therapeutics Inc 是一家生物技术公司,旨在通过结合抗体工程,合理的治疗组合和精确的医学方法来为患者选择,创造下一代炎症性肠病产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101014818ab8cb3d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101014818ab8cb3d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SYRE","BK4139"],"gpt_icon":0},{"id":"2477360596","title":"Spyre Therapeutics, Inc.盘中异动 临近收盘急速上涨5.06%报34.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477360596","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477360596?lang=zh_cn&edition=full","pubTime":"2024-10-23 03:53","pubTimestamp":1729626836,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日03时53分,Spyre Therapeutics, Inc.股票出现波动,股价急速上涨5.06%。Spyre Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.96%。Spyre Therapeutics, Inc.公司简介:Spyre Therapeutics Inc 是一家生物技术公司,旨在通过结合抗体工程,合理的治疗组合和精确的医学方法来为患者选择,创造下一代炎症性肠病产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023035357971a1a98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023035357971a1a98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","SYRE"],"gpt_icon":0},{"id":"2475103125","title":"美国研究综述-Cadence Design Systems、Equity Bancshares、标普全球","url":"https://stock-news.laohu8.com/highlight/detail?id=2475103125","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475103125?lang=zh_cn&edition=full","pubTime":"2024-10-15 15:19","pubTimestamp":1728976782,"startTime":"0","endTime":"0","summary":" 路透10月15日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价,其中包括 Cadence Design Systems、Equity Bancshares 和 S&P Global。公司要闻 * APA公司 :Piper Sandler将目标价从29美元下调至28美元 * Cadence Design Systems Inc :贝伦贝格给予买入评级 * Equity Bancshares Inc :Stephens将其评级从等权上调至增持 * S&P Global Inc :摩根大通将目标价从565美元上调至600美元 * Vital Energy Inc :Piper Sandler将目标价从38美元下调至37美元 以下是路透周二报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1923622614.USD","BNTC","DVN","LU1978683503.SGD","CHRD","LU1883866441.USD","SPGI","LU0345780950.USD","LU1815336760.USD","STR","LU1430597077.USD","VNOM","EQBK","XOM","LU2250418816.HKD","LU0823414478.USD","BUSE","LU1267930813.SGD","MRNA","PWR","BK4213","LU0985320562.USD","LU0823414551.USD","CDNS","AFG","SYRE","SNPS","LU1839511570.USD","VTLE","LU0505663152.USD","MCO","LU0957791311.USD","LU0719512351.SGD","BX","FANG","FCX","LU1989764664.SGD","LVS","ENPH","LU1582987597.SGD","LU1861219969.SGD","LU0889566641.SGD","MUR","APA","IE00BWXC8680.SGD","MSCI","KEY","PR","LBPH","LU2355687059.USD"],"gpt_icon":0},{"id":"2472356894","title":"Spyre Therapeutics, Inc.盘中异动 股价大涨5.09%报29.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472356894","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472356894?lang=zh_cn&edition=full","pubTime":"2024-10-01 03:50","pubTimestamp":1727725853,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日03时50分,Spyre Therapeutics, Inc.股票出现异动,股价急速上涨5.09%。截至发稿,该股报29.94美元/股,成交量14.7904万股,换手率0.29%,振幅5.05%。Spyre Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.13%。Spyre Therapeutics, Inc.公司简介:Spyre Therapeutics Inc 是一家生物技术公司,旨在通过结合抗体工程,合理的治疗组合和精确的医学方法来为患者选择,创造下一代炎症性肠病产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001035053ab673308&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001035053ab673308&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SYRE","BK4139"],"gpt_icon":0},{"id":"2470401458","title":"Spyre Therapeutics, Inc.盘中异动 股价大跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470401458","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470401458?lang=zh_cn&edition=full","pubTime":"2024-09-24 21:33","pubTimestamp":1727184784,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日21时33分,Spyre Therapeutics, Inc.股票出现异动,股价快速跳水5.22%。Spyre Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.78%。Spyre Therapeutics, Inc.公司简介:Spyre Therapeutics Inc 是一家生物技术公司,旨在通过结合抗体工程,合理的治疗组合和精确的医学方法来为患者选择,创造下一代炎症性肠病产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409242133049f132428&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409242133049f132428&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SYRE","LENZ"],"gpt_icon":0},{"id":"2468689262","title":"Spyre Therapeutics, Inc.盘中异动 下午盘股价大涨5.04%报30.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468689262","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468689262?lang=zh_cn&edition=full","pubTime":"2024-09-20 02:31","pubTimestamp":1726770716,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日02时31分,Spyre Therapeutics, Inc.股票出现异动,股价大幅拉升5.04%。Spyre Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.14%。Spyre Therapeutics, Inc.公司简介:Spyre Therapeutics Inc 是一家生物技术公司,旨在通过结合抗体工程,合理的治疗组合和精确的医学方法来为患者选择,创造下一代炎症性肠病产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920023156a1db3a3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920023156a1db3a3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","SYRE"],"gpt_icon":0},{"id":"2457114825","title":"Spyre Therapeutics Inc 预计每股亏损 95 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2457114825","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457114825?lang=zh_cn&edition=full","pubTime":"2024-08-07 23:31","pubTimestamp":1723044684,"startTime":"0","endTime":"0","summary":" * Spyre Therapeutics Inc 预计将在8月9日公布截至2024年6月30日的业绩() 时显示季度收入增长 * 根据LSEG的数据,5位分析师的平均预期显示,这家总部位于马萨诸塞州沃尔瑟姆的公司的营收预计将从一年前的68.8万美元增长481.4%,达到400万美元。* LSEG 分析师对 Spyre Therapeutics Inc 的平均预期是每股亏损 95 美分。* 华尔街对 Spyre Therapeutics Inc 的 12 个月目标价中位数为 50.00 美元,高于其最新收盘价 26.04 美元。8月7日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SYRE","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.spyre.com","stockEarnings":[{"period":"1week","weight":-0.0108},{"period":"1month","weight":-0.1324},{"period":"3month","weight":-0.2091},{"period":"6month","weight":-0.01},{"period":"1year","weight":0.3856},{"period":"ytd","weight":0.1087}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Spyre Therapeutics, Inc.于2013年12月16日从特拉华州有限责任公司转换而来。该公司是一家生物技术公司,旨在通过结合同类最佳的抗体工程、合理的治疗组合以及用于患者选择的精准医疗方法,创造下一代炎症性肠病(IBD)产品。Spyre的产品线包括针对α4β7、TL1A和IL-23的延长半衰期抗体。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.048662},{"month":2,"riseRate":0.5,"avgChangeRate":0.010915},{"month":3,"riseRate":0.5,"avgChangeRate":0.028824},{"month":4,"riseRate":0.125,"avgChangeRate":-0.064934},{"month":5,"riseRate":0.444444,"avgChangeRate":-0.065599},{"month":6,"riseRate":0.444444,"avgChangeRate":0.134669},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.017321},{"month":8,"riseRate":0.888889,"avgChangeRate":0.124194},{"month":9,"riseRate":0.555556,"avgChangeRate":0.01653},{"month":10,"riseRate":0.333333,"avgChangeRate":0.070501},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.019556},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.029529}],"exchange":"NASDAQ","name":"SPYRE THERAPEUTICS INC","nameEN":"SPYRE THERAPEUTICS INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SPYRE THERAPEUTICS INC(SYRE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供SPYRE THERAPEUTICS INC(SYRE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"SPYRE THERAPEUTICS INC,SYRE,SPYRE THERAPEUTICS INC股票,SPYRE THERAPEUTICS INC股票老虎,SPYRE THERAPEUTICS INC股票老虎国际,SPYRE THERAPEUTICS INC行情,SPYRE THERAPEUTICS INC股票行情,SPYRE THERAPEUTICS INC股价,SPYRE THERAPEUTICS INC股市,SPYRE THERAPEUTICS INC股票价格,SPYRE THERAPEUTICS INC股票交易,SPYRE THERAPEUTICS INC股票购买,SPYRE THERAPEUTICS INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SPYRE THERAPEUTICS INC(SYRE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供SPYRE THERAPEUTICS INC(SYRE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}